Mankind Pharma Limited (MANKIND) reported a 11.8% revenue increase and an adjusted EBITDA margin of 27.1% in Q4 FY26.
Viyash Scientific Limited (VIYASH) reports record Q4 FY26 results with EBITDA surpassing Rs. 200 Cr and PAT up by 306%.
Zota Health Care Limited (ZOTA) announces brand expansion with Mr. Akshay Kumar as brand ambassador for UGO Generic, enhancing national presence.
Nephrocare Health Services Limited (NEPHROPLUS) reports Q4 FY26 revenue up 21.2% to ₹265.6 crore, adjusted EBITDA rises 2.6% to ₹55.4 crore.
ZIM Laboratories Limited (ZIMLAB) secures MA for Dabigatran Etexilate in Italy and Europe, boosting global commercial opportunities.
Amanta Healthcare Limited (NSE: AMANTA) announces Q4 & FY26 results with consistent revenue momentum and 42% YoY profit growth in FY26.
Zydus Lifesciences Limited (ZYDUSLIFE) reports a 16% YoY revenue growth for Q4 FY26, with EBITDA margin improving to 33.7%.
Healthcare Global Enterprises Limited (HCG) launches its new cancer hospital in North Bengaluru, introducing Karnataka’s first MR-Linac.
Lupin Limited (LUPIN) makes its debut in Dow Jones Best-in-Class Indices 2026, highlighting its strong ESG performance and commitment to sustainability.
GPT Healthcare Limited (NSE: GPTHEALTH) reported a 24.30% y-o-y revenue growth for Q4 FY26, reaching Rs. 128.0 crore.